Sunflower Pharmaceutical Group Co.,Ltd

SZSE:002737 Stok Raporu

Piyasa değeri: CN¥13.5b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Sunflower Pharmaceutical GroupLtd Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Sunflower Pharmaceutical GroupLtd 'nin toplam hissedar özsermayesi CN¥5.3B ve toplam borcu ise CN¥13.7M, bu da borç/özsermaye oranını 0.3% değerine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla CN¥7.1B ve CN¥1.9B şeklindedir. Sunflower Pharmaceutical GroupLtd 'nin FVÖK'ü CN¥978.3M olup, faiz karşılama oranı -11.2 dur. CN¥3.8B tutarında nakit ve kısa vadeli yatırımları vardır.

Anahtar bilgiler

0%

Borç/özkaynak oranı

CN¥0

Borç

Faiz karşılama oranı-14.3x
NakitCN¥2.50b
EşitlikCN¥4.61b
Toplam yükümlülüklerCN¥1.64b
Toplam varlıklarCN¥6.25b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Aug 26
A Look At The Intrinsic Value Of Sunflower Pharmaceutical Group Co.,Ltd (SZSE:002737)

Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Jul 19
Lacklustre Performance Is Driving Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Low P/E

Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Jun 07
Sunflower Pharmaceutical GroupLtd's (SZSE:002737) Shareholders Will Receive A Bigger Dividend Than Last Year

Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

May 06
Earnings Troubles May Signal Larger Issues for Sunflower Pharmaceutical GroupLtd (SZSE:002737) Shareholders

Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

Apr 16
Sunflower Pharmaceutical Group Co.,Ltd's (SZSE:002737) Subdued P/E Might Signal An Opportunity

We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Mar 04
We Ran A Stock Scan For Earnings Growth And Sunflower Pharmaceutical GroupLtd (SZSE:002737) Passed With Ease

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 002737's short term assets (CN¥4.2B) exceed its short term liabilities (CN¥1.3B).

Uzun Vadeli Yükümlülükler: 002737's short term assets (CN¥4.2B) exceed its long term liabilities (CN¥352.6M).

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 002737 is debt free.

Borcun Azaltılması: 002737 has no debt compared to 5 years ago when its debt to equity ratio was 16%.

Borç Kapsamı: 002737 has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: 002737 has no debt, therefore coverage of interest payments is not a concern.

Bilanço

Sağlıklı şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y